BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Molecular glue development continues to thrive\, offering exci
 ting opportunities to target previously undruggable proteins and treat a 
 wide range of diseases. 2024 has seen a multitude of collaborations\, wit
 h Takeda and Degron Therapeutics entering a deal worth $1.2 billion.\n\nT
 he 3rd Molecular Glue Drug Development Summit returns as the only industr
 y-dedicated forum bringing together 90+ experts as they showcase the late
 st advancements and breakthroughs in molecular glue drug development thro
 ugh discussions and data-driven case studies on screening tools\, novel m
 echanisms of actions of proximity-based degrading and non-degrading molec
 ular glues and lead optimization strategies\, to streamline discovery and
  development of safe and effective glues.\n\nURLs:\nWebsite: https://ter.
 li/eu7mbj\nTickets: https://ter.li/yyn4gc\nBrochure: https://ter.li/6rnt8
 q\n\nPrices:\nDrug Developer Pricing - Full Access Pass (Conference + 2 W
 orkshops): USD 4197.00\,\nDrug Developer Pricing - 3 Day Pass (Conference
  + 1 Workshop): USD 3598.00\,\nDrug Developer Pricing - 2 Day Pass (Confe
 rence Only): USD 2999.00\,\nAcademic Pricing - Full Access Pass (Conferen
 ce + 2 Workshops): USD 3597.00\,\nAcademic Pricing - 3 Day Pass (Conferen
 ce + 1 Workshop): USD 3098.00\,\nAcademic Pricing - 2 Day Pass (Conferenc
 e Only): USD 2599.00\,\nService and Solution Provider Pricing - Full Acce
 ss Pass (Conference + 2 Workshops): USD 5097.00\,\nService and Solution P
 rovider Pricing - 3 Day Pass (Conference + 1 Workshop): USD 4398.00\,\nSe
 rvice and Solution Provider Pricing - 2 Day Pass (Conference Only): USD 3
 699.00\n\nSpeakers: Andres Hernandez\, de la Pena Principal Scientist\, N
 eomorph\, Andrew Potterton\, Head of Technology Platform\, Adhesion Thera
 peutics\, Benedict Cross\, Chief Technology Officer and Head of Platform\
 , PhoreMost\, Bin Liu\, Chief Executive Officer\, HB Therapeutics\, Inc.\
 , Bradlee Heckmann\, Co-founder and Chief Scientific Officer\, ASHA thera
 peutics\, Dmitri Ivanov\, Associate Professor Biochemistry and Structural
  Biology\, University of Texas Health San Antonio\, Dong Seok Kim\, Chief
  Executive Officer\, AevisBio Inc.\, Fan Liu\, Co-Founder and Chief Techn
 ology Officer\, NeoX Biotech Inc.\, Felix Hausch Professor\, Technical Un
 iversity of Darmstadt\, Feng Wang\, Senior Principal Scientist and Lab He
 ad Protein Homeostasis Discovery Sciences\, Pfizer\, Jacob Hale\, Senior 
 Scientist\, Novartis\, Julia Dou\, Director of Protein Chemistry\, Degron
  Therapeutics\, Markus Queisser\, Scientific Director\, GlaxoSmithKline P
 lc\, Matthew Hayward\, Vice President of Drug Discovery\, Magnet Biomedic
 ine\, Matthias Brand\, Chief Technology Officer\, Proxygen GmbH\, Meizhon
 g Jin\, Senior Director - Oncology Chemistry\, AstraZeneca\, Peggy Thomps
 on\, Vice President and Head of Biology\, Plexium Inc.\, Rana Quraishi\, 
 Chief Executive Officer\, Isoprene Pharmaceuticals\, Rick Ewing\, Vice Pr
 esident and Head of Chemistry\, Rapafusyn Pharmaceuticals\, Tauseef Butt\
 , President and Chief Executive Officer\, Progenra\, Vivek Vishnudas\, Vi
 ce President - Drug Discovery Non Clinical Development\, Chief Technology
  Officer\, Site Head of Research and Development\, BPGBio Inc.\, Yao Wang
 \, Chief Medical Officer\, Kangpu Biopharmaceuticals\n\nCategory: Confere
 nces | Science\, Health and Medicine | Pharmaceuticals\n\nDate and Time: 
 28th January 2025 at 8:00 am to 30th January 2025 at 4:45 pm\n\nVenue det
 ails: The Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Boston\, Mas
 sachusetts\, 02142\, United States\n
DTEND:20250130T164500
DTSTAMP:20260512T231937Z
DTSTART:20250128T080000
LOCATION:The Royal Sonesta Boston\, 40\, Edwin H Land Boulevard\, Boston\,
  Massachusetts\, 02142\,
SEQUENCE:0
SUMMARY:Molecular glue development continues to thrive\, offering exciting
  opportunities to target previously undruggable proteins and treat a wide
  range of...
UID:9a25eff1-b27c-4272-9588-fb3fd1b2b284
END:VEVENT
END:VCALENDAR
